KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy |
|
https://doi.org/10.18632/oncotarget.25180
Gemma Bruera,
Francesco Pepe,
Umberto Malapelle,
Pasquale Pisapia,
Antonella Dal Mas,
Daniela Di Giacomo,
Giuseppe Calvisi,
Giancarlo Troncone,
and Enrico Ricevuto
|
| 26279-26290 |
Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer
Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with high-risk prostate cancer |
|
https://doi.org/10.18632/oncotarget.25207
Yoon Seok Suh,
Jae Young Joung,
Sung Han Kim,
Jeong Eun Kim,
Moon Kyung Choi,
Weon Seo Park,
Sang-Jin Lee,
Ho Kyung Seo,
Jinsoo Chung,
and Kang Hyun Lee
|
| 26291-26298 |
Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively
Steviol, a natural product inhibits proliferation of the gastrointestinal cancer cells intensively |
|
https://doi.org/10.18632/oncotarget.25233
Junming Chen,
Yongmei Xia,
Xiaochen Sui,
Qingrui Peng,
Tongtong Zhang,
Jian Li,
and Jue Zhang
|
| 26299-26308 |
Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia
Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.25241
Hélène Cabanas,
Thomas Harnois,
Christophe Magaud,
Laëtitia Cousin,
Bruno Constantin,
Nicolas Bourmeyster,
and Nadine Déliot
|
| 26309-26327 |
Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus
Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus |
|
https://doi.org/10.18632/oncotarget.25242
Sarah L. Hulin-Curtis,
James A. Davies,
Rachel Jones,
Emma Hudson,
Louise Hanna,
John D. Chester,
and Alan L. Parker
|
| 26328-26341 |
PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2
PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2 |
|
https://doi.org/10.18632/oncotarget.25254
Ya-Min Cheng,
Po-Lin Lin,
De-Wei Wu,
Lee Wang,
Chi-Chou Huang,
and Huei Lee
|
| 26342-26352 |
Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia
Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.25293
Joachim R. Göthert,
Roze Imsak,
Michael Möllmann,
Stefanie Kesper,
Maria Göbel,
Ulrich Dührsen,
Arne Scholz,
Ulrich Lücking,
Matthias Baumann,
Anke Unger,
Carsten Schultz-Fademrecht,
Bert Klebl,
Jan Eickhoff,
Axel Choidas,
and Jan Dürig
|
| 26353-26369 |
Oleanolic acid induces p53-dependent apoptosis via the ERK/JNK/AKT pathway in cancer cell lines in prostatic cancer xenografts in mice
Oleanolic acid induces p53-dependent apoptosis via the ERK/JNK/AKT pathway in cancer cell lines in prostatic cancer xenografts in mice |
|
https://doi.org/10.18632/oncotarget.25316
Gyeong-Ji Kim,
Hyeon-Ju Jo,
Kwon-Jai Lee,
Jeong Woo Choi,
and Jeung Hee An
|
| 26370-26386 |
Differential miRNA expression profiling reveals miR-205-3p to be a potential radiosensitizer for low- dose ionizing radiation in DLD-1 cells
Differential miRNA expression profiling reveals miR-205-3p to be a potential radiosensitizer for low- dose ionizing radiation in DLD-1 cells |
|
https://doi.org/10.18632/oncotarget.25405
Rodrigo Andaur,
Julio C. Tapia,
José Moreno,
Leopoldo Soto,
Ricardo Armisen,
and Katherine Marcelain
|
| 26387-26405 |
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy |
|
https://doi.org/10.18632/oncotarget.25413
Angela Santonja,
Alfonso Sánchez-Muñoz,
Ana Lluch,
Maria Rosario Chica-Parrado,
Joan Albanell,
José Ignacio Chacón,
Silvia Antolín,
José Manuel Jerez,
Juan de la Haba,
Vanessa de Luque,
Cristina Elisabeth Fernández-De Sousa,
Luis Vicioso,
Yéssica Plata,
César Luis Ramírez-Tortosa,
Martina Álvarez,
Casilda Llácer,
Irene Zarcos-Pedrinaci,
Eva Carrasco,
Rosalía Caballero,
Miguel Martín,
and Emilio Alba
|
| 26406-26416 |
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling
Distinct age-associated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling |
|
https://doi.org/10.18632/oncotarget.25443
Katherine Tarlock,
Shan Zhong,
Yuting He,
Rhonda Ries,
Eric Severson,
Mark Bailey,
Samantha Morley,
Sohail Balasubramanian,
Rachel Erlich,
Doron Lipson,
Geoff A. Otto,
Jo-Anne Vergillo,
E. Anders Kolb,
Jeffrey S. Ross,
Tariq Mughal,
Philip J. Stephens,
Vincent Miller,
Soheil Meshinchi,
and Jie He
|
| 26417-26430 |
Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics
Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics |
|
https://doi.org/10.18632/oncotarget.25449
Xiaoying Ye,
Brian T. Luke,
Bih-Rong Wei,
Jan A. Kaczmarczyk,
Jadranka Loncarek,
Jennifer E. Dwyer,
Donald J. Johann,
Richard G. Saul,
Dwight V. Nissley,
Frank McCormick,
Gordon R. Whiteley,
and Josip Blonder
|
| 26431-26452 |
Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process
Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process |
|
https://doi.org/10.18632/oncotarget.25458
Dorothée Faille,
Marie-Charlotte Bourrienne,
Emmanuelle de Raucourt,
Luc de Chaisemartin,
Vanessa Granger,
Romaric Lacroix,
Laurence Panicot-Dubois,
Pascal Hammel,
Philippe Lévy,
Philippe Ruszniewski,
Nadine Ajzenberg,
and Vinciane Rebours
|
| 26453-26465 |
Folic acid–conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action
Folic acid–conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action |
|
https://doi.org/10.18632/oncotarget.25470
Khaled AbouAitah,
Anna Swiderska-Sroda,
Ahmed A. Farghali,
Jacek Wojnarowicz,
Agata Stefanek,
Stanislaw Gierlotka,
Agnieszka Opalinska,
Abdou K. Allayeh,
Tomasz Ciach,
and Witold Lojkowski
|
| 26466-26490 |
Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells
Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells |
|
https://doi.org/10.18632/oncotarget.25474
Karin Bauer,
Daniela Berger,
Christoph C. Zielinski,
Peter Valent,
and Thomas W. Grunt
|
| 26491-26506 |
Biologic canine and human intervertebral disc repair by notochordal cell-derived matrix: from bench towards bedside
Biologic canine and human intervertebral disc repair by notochordal cell-derived matrix: from bench towards bedside |
|
https://doi.org/10.18632/oncotarget.25476
Frances C. Bach,
Anna R. Tellegen,
Martijn Beukers,
Alberto Miranda-Bedate,
Michelle Teunissen,
Willem A.M. de Jong,
Stefan A.H. de Vries,
Laura B. Creemers,
Karin Benz,
Björn P. Meij,
Keita Ito,
and Marianna A. Tryfonidou
|
| 26507-26526 |
Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells
Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25480
Fiorella Vanderhoeven,
Analía Lourdes Redondo,
Ana Laura Martinez,
Laura María Vargas-Roig,
Angel Matias Sanchez,
and Marina Inés Flamini
|
| 26527-26542 |
Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma
Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma |
|
https://doi.org/10.18632/oncotarget.25489
Manuela Krumbholz,
Wilhelm Woessmann,
Jakob Zierk,
David Seniuk,
Paolo Ceppi,
Martin Zimmermann,
Vijay Kumar Singh,
Markus Metzler,
and Christine Damm-Welk
|
| 26543-26555 |
Hypoxia-targeted gold nanorods for cancer photothermal therapy
Hypoxia-targeted gold nanorods for cancer photothermal therapy |
|
https://doi.org/10.18632/oncotarget.25492
Yuan Chen,
Xiaomei Bian,
Maureen Aliru,
Amit A. Deorukhkar,
Oscar Ekpenyong,
Su Liang,
Jyothy John,
Jing Ma,
Xiuqing Gao,
Jon Schwartz,
Pankaj Singh,
Yuanqing Ye,
Sunil Krishnan,
and Huan Xie
|
| 26556-26571 |
A novel role of metal response element binding transcription factor 2 at the Hox gene cluster in the regulation of H3K27me3 by polycomb repressive complex 2
A novel role of metal response element binding transcription factor 2 at the Hox gene cluster in the regulation of H3K27me3 by polycomb repressive complex 2 |
|
https://doi.org/10.18632/oncotarget.25505
Abdul Aziz Khan,
Seok-Jin Ham,
Le Ngoc Yen,
Haeng Lim Lee,
Jounghyun Huh,
Hyeongrin Jeon,
Myoung Hee Kim,
and Tae-Young Roh
|
| 26572-26585 |
Prostaglandins in the pathogenesis of kidney diseases
Prostaglandins in the pathogenesis of kidney diseases |
|
https://doi.org/10.18632/oncotarget.25005
Yuanyuan Li,
Weiwei Xia,
Fei Zhao,
Zhaoying Wen,
Aihua Zhang,
Songming Huang,
Zhanjun Jia,
and Yue Zhang
|
| 26586-26602 |
